Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reuben S Harris

Showing results (201-210 of 267) with videos related to

Pageof 27
Sort By:
Elife|September 28, 2020
Characterization of the mechanism by which the RB/E2F pathway controls expression of the cancer genomic DNA deaminase APOBEC3BPieter A Roelofs, Chai Yeen Goh, Boon Haow Chua, et al.
British Journal of Cancer|February 16, 2026
Correction to: Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cellsJenni Nikkilä, Rahul Kumar, James Campbell, et al.
Nature Communications|June 21, 2020
Structural basis of host protein hijacking in human T-cell leukemia virus integrationVeer Bhatt, Ke Shi, Daniel J Salamango, et al.
British Journal of Cancer|May 24, 2017
Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cellsJenni Nikkilä, Rahul Kumar, James Campbell, et al.
Science Translational Medicine|October 4, 2022
SARS-CoV-2 3CL<sup>pro</sup> mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376Emmanuel Heilmann, Francesco Costacurta, Seyed Arad Moghadasi, et al.
Nature Structural & Molecular Biology|December 20, 2016
Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3BKe Shi, Michael A Carpenter, Surajit Banerjee, et al.
Nature Microbiology|November 14, 2018
Epstein-Barr virus BORF2 inhibits cellular APOBEC3B to preserve viral genome integrityAdam Z Cheng, Jaime Yockteng-Melgar, Matthew C Jarvis, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 19, 2024
Vulnerability to APOBEC3G linked to the pathogenicity of deltaretrovirusesTakafumi Shichijo, Jun-Ichirou Yasunaga, Kei Sato, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
<i>Mus Musculus</i> papillomavirus MmuPV1 resists restriction by human APOBEC3BXingyu Liu, Andrea Bilger, Denis Lee, et al.
Biorxiv : the Preprint Server for Biology|August 19, 2022
Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitorsSeyed Arad Moghadasi, Emmanuel Heilmann, Ahmed Magdy Khalil, et al.
Pageof 27

Showing results (201-210 of 267) with videos related to

Sort By:
Pageof 27
Elife|September 28, 2020
Characterization of the mechanism by which the RB/E2F pathway controls expression of the cancer genomic DNA deaminase APOBEC3BPieter A Roelofs, Chai Yeen Goh, Boon Haow Chua, et al.
British Journal of Cancer|February 16, 2026
Correction to: Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cellsJenni Nikkilä, Rahul Kumar, James Campbell, et al.
Nature Communications|June 21, 2020
Structural basis of host protein hijacking in human T-cell leukemia virus integrationVeer Bhatt, Ke Shi, Daniel J Salamango, et al.
British Journal of Cancer|May 24, 2017
Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cellsJenni Nikkilä, Rahul Kumar, James Campbell, et al.
Science Translational Medicine|October 4, 2022
SARS-CoV-2 3CL<sup>pro</sup> mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376Emmanuel Heilmann, Francesco Costacurta, Seyed Arad Moghadasi, et al.
Nature Structural & Molecular Biology|December 20, 2016
Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3BKe Shi, Michael A Carpenter, Surajit Banerjee, et al.
Nature Microbiology|November 14, 2018
Epstein-Barr virus BORF2 inhibits cellular APOBEC3B to preserve viral genome integrityAdam Z Cheng, Jaime Yockteng-Melgar, Matthew C Jarvis, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 19, 2024
Vulnerability to APOBEC3G linked to the pathogenicity of deltaretrovirusesTakafumi Shichijo, Jun-Ichirou Yasunaga, Kei Sato, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
<i>Mus Musculus</i> papillomavirus MmuPV1 resists restriction by human APOBEC3BXingyu Liu, Andrea Bilger, Denis Lee, et al.
Biorxiv : the Preprint Server for Biology|August 19, 2022
Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitorsSeyed Arad Moghadasi, Emmanuel Heilmann, Ahmed Magdy Khalil, et al.
Pageof 27